Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis. Reumatismo [Internet]. 2013 May 27 [cited 2025 Jun. 7];65(2):75-8. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2013.75